Danish biotech giant Novozymes narrowed the range of its full year outlook to the lower end as the firm reported a 17% rise in Q3 net profits and strong sales in Food & Beverages and feed and Agriculture & Feed.
Novozymes lowers full year outlook despite strong food and feed performances
dimanche 25 octobre 2015
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire